Search results
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 13 hours agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 3 days agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 3 days agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 3 days agoAstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 6 days agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 3 days agoOn Monday, Deutsche Bank reiterated a Hold rating and a price target of GBP110.00 on stock of ...
AstraZeneca invests in Nucleus RadioPharmaceuticals - Minneapolis / St. Paul Business Journal
The Business Journals· 1 day agoAfter completing a $56 million Series A funding round in 2023, Nucleus RadioPharma scored an...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 14 hours agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 1 day ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court adopted a magistrate judge’s recommendations ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 15 hours agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...